Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 8, 2009

Scientists Find New Link between Osteoporosis and Celiac Disease

  • People with celiac disease may develop osteoporosis because their immune system attacks their bone tissue, according to researchers from the University of Edinburgh. They studied a protein called osteoprotegerin (OPG), which in healthy people plays a crucial role in maintaining bone health by controlling the rate at which bone tissue is removed.

    The study appears in the New England Journal of Medicine in a paper titled "Osteoporosis Associated with Neutralizing Autoantibodies against Osteoprotegerin."

    The results showed that 20% of the celiac patients they evaluated produced antibodies that attack the OPG protein and stop it from working properly. This led to rapid bone destruction and severe osteoporosis.

    It was previously thought that osteoporosis developed in celiac patients because they cannot properly absorb calcium and vitamin D from their diet. The team found that this new form of osteoporosis did not respond to calcium and vitamin D supplements, but it could be treated with drugs that prevent bone loss.


Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »